Description
Cagrilintide 10mg is an investigational long-acting amylin analog developed to support research into appetite regulation, metabolic function, and body weight management. By mimicking the actions of the naturally occurring hormone amylin, cagrilintide is designed to interact with amylin and calcitonin receptors involved in hunger signaling and energy balance.
Research suggests that cagrilintide may help promote feelings of fullness, reduce appetite, and slow gastric emptying, mechanisms that contribute to reduced caloric intake and improved weight management outcomes. Unlike GLP-1 receptor agonists, cagrilintide acts through distinct biological pathways, making it an important area of study for understanding complementary approaches to metabolic regulation.
Cagrilintide has been extensively investigated both as a standalone therapy and in combination with semaglutide, a treatment approach commonly referred to as CagriSema. Clinical studies have demonstrated promising results in weight management research, with participants experiencing significant reductions in body weight and improvements in metabolic markers. Researchers are also evaluating its potential effects on glucose regulation and overall metabolic health.
As interest in peptide-based metabolic therapies continues to grow, cagrilintide remains an important focus of ongoing scientific investigation into appetite control, energy balance, obesity research, and metabolic disease management.
Package Includes
- (1) Vial of Lyophilized Peptide Powder
Important Notes
- Bacteriostatic water is required for reconstitution and is not included.
- Syringes and additional laboratory supplies are not included.
- All peptides are intended exclusively for research applications.
For laboratory research use only. Not intended for human or animal consumption, medical use, diagnosis, treatment, or prevention of any disease.
